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Background :  
Skin fibrotic disorders such as systemic sclerosis (SSc) are characterized by an excessive 
accumulation of extracellular matrix (ECM), and develop under the influence of certain 
cytokines. We previously established a mouse model of skin fibrosis induced by exogenous 
application of cytokines. We have revealed that both the number of macrophages and the 
levels of macrophage chemoattractant protein-1 (MCP-1) mRNA positively correlate with the 
extent of skin fibrosis. Macrophages can be divided into two subsets, the first expressing 
CCR2, and the second expressing CX3CR1. 
Objective :  
To elucidate the role of skin infiltrating macrophages based on CCR2 and CX3CR1 in this 
cytokine-induced murine fibrosis model. 
Methods :  
We  examined the amounts of collagen deposited in granulation tissues, the numbers of 
macrophages and the levels of several mRNA in wild type (WT) mice, CCR2-/- mice, and 
CX3CR1-/- mice during injections of transforming growth factor-β (TGF-β) followed by 
injections of connective tissue growth factor (CTGF).  
Results :  
TGF-β injection increased the expressions of MCP-1, fractalkine, CCR2 and CX3CR1 
mRNA in WT mice. The overproduction of collagen induced by TGF-β was significantly 
reduced by CCR2 deficiency, while collagen contents induced by CTGF were restored to 
wild-type levels. In contrast, overproduction of collagen in CX3CR1-deficient mice was 
decreased nearly 50% by both TGF-β and CTGF stimulations.  
Conclusion :  
The involvement of CCR2/MCP-1 interaction (CCR2-dependent loop) was during the 
TGF-β phase. In contrast, the fractalkine/CX3CR1 interaction contributes to the initiation of 
fibrosis by TGF-β and its maintenance by CTGF. Collectively, two subsets of macrophages 




SSc is an autoimmune rheumatic disease characterized by fibrosis and vascular injury in the 
skin and multiple internal organs. The etiology and pathogenesis of SSc remain unclear. 
Clinically, SSc is typified by excessive collagen deposition, vascular damage, and 
immunological activation and these clinical features likely interrelated [1] [2] [3] [4]. The 
central event in the pathogenesis of SSc is an abnormal accumulation of extracellular matrix 
(ECM) components, predominantly type I and III collagen. The mechanisms that cause 
excessive fibrosis in SSc remain incompletely understood, however, many studies have 
suggested that cytokine release from inflammatory cells, endothelial cells, fibroblasts, and 
other cell types in the involved organs play important roles in the initiation and maintenance 
of fibrosis [5] [6]. 
Among these cytokines, transforming growth factor-β (TGF-β) and connective 
tissue growth factor (CTGF) are thought to play central roles in the pathogenesis of SSc [7] 
[8]. To better understand the mechanisms of fibrosis and the contributions of cytokines, we 
established a unique animal model of skin fibrosis by exogenously administering cytokines 
[9]. In this model, the in vivo effects of cytokines are examined following subcutaneous 
injection into newborn mice. We found previously that TGF-β induced only transient fibrosis 
on day 4, despite 7 days of consecutive injections [10]. By contrast, serial injections of CTGF 
after TGF-β administration caused persistent fibrosis [11]. We also identified a positive 
correlation between the number of macrophages present, MCP-1 mRNA expression levels, 
and the extent of skin fibrosis [12]. This finding suggested that macrophages and macrophage 
related cytokines might indirectly contribute to the development of fibrosis. 
Activated macrophages appear to play an important role in fibrosis because they are among 
the first immune cells recruited during the initial stages of fibrosis. It has long been known 
that early SSc skin contains an increased number of CD14-positive cells 
(monocytes/macrophages), compared to normal skin [13]. When activated, macrophages 
release a number of pro-inflammatory and fibrogenic mediators, such as TGF-β and 
platelet-derived growth factor (PDGF) [14].  Macrophages are classified into two functional 
subsets based on their chemokine receptor expression pattern: a short-lived CCR2 subset that 
is actively recruited to inflamed tissues, and a CX3CR1 subset characterized as resident in 
non-inflamed tissues [15]. CCR2 is a major receptor for MCP-1, while CX3CR1 is a receptor 
for fractalkine, a chemokine expressed by endothelial cells.  
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 MCP-1 stimulates collagen production by fibroblasts via endogenous upregulation 
of TGF-β expression [16]. Previous studies have demonstrated that MCP-1 gene expression is 
increased during bleomycin-induced pulmonary fibrosis in mice [17] and interstitial kidney 
fibrosis [18]. In SSc patients, serum levels of MCP-1 are elevated, and spontaneous MCP-1 
production by peripheral blood mononuclear cells is increased relative to normal controls [19]. 
MCP-1 is also strongly expressed in the epidermis, in inflammatory mononuclear cells, and in 
endothelial cells in the sclerotic skin of SSc patients, but it is not expressed in normal skin. 
Administration of anti-MCP-1 neutralizing antibody reduced skin sclerosis in 
bleomycin-treated mice [20]. Furthermore, mice deficient for the MCP-1 receptor CCR2 are 
protected from fluoresceinisothiocyanate-induced and bleomycin-induced lung fibrosis [21] 
[22]. Thus, it appears that MCP-1 is critically involved in the pathogenesis of SSc. 
 Fractalkine is a membrane-bound chemokine that functions not only as a 
chemoattractant but also as an adhesion molecule, and it is expressed on proinflammatory 
cytokine activated endothelial cells. The fractalkine receptor, CX3CR1, is expressed on 
mature monocytes, NK cells, and cytotoxic effector T cells [23]. We previously demonstrated 
that fractalkine was strongly expressed on endothelial cells in affected skin and lung tissues in 
SSc patients. Additionally, soluble fractalkine levels were significantly elevated in sera and 
were associated with the existence of digital ischemia, and severe pulmonary fibrosis. The 
number of CX3CR1-expressing cells, including monocytes, was increased in the lesional skin 
and lung tissues from SSc patients with diffuse cutaneous involvement. [24]. Collectively, 
these data suggest a role for fractalkine as a major mediator of SSc. 
 In this study, we have investigated whether CCR2/MCP-1 or CX3CR1/fractalkine 
play a role in the induction and maintenance of skin fibrosis in our animal model, to 
determine if these molecules might be useful as novel therapeutic targets in fibrotic disorders.  
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2. Materials and Methods 
2.1 Mice 
Specific pathogen-free 8-to 10-week-old female BALB/c mice (WT mice) were purchased 
from Charles River Japan (Yokohama, Japan). CCR2-deficient (CCR2-/-) mice and 
CX3CR1-deficient (CX3CR1-/-) mice were generated [25] [26] and backcrossed to a BALB/c 
background for more than 8 generations in our animal facility. All studies and procedures 
were approved by the Committee on Animal Experimentation of Kanazawa University 
Graduate School of Medical Science. 
 
2.2 Growth factors   
Human recombinant TGF-β3 was purchased from R&D Systems, Inc. (Minneapolis, MN). 
Human recombinant CTGF was a generous gift from Nosan Corporation. (Yokohama, Japan). 
Endotoxin levels of TGF and CTGF were <1.0 EU per 1 µg of cytokine as determined by the 
LAL method respectively. 
 
2.3 In vivo experimental model 
TGF-β3 and CTGF were dissolved in phosphate-buffered saline (PBS), to obtain final 
concentrations of 40 and 20 ng/µl, respectively. Newborn mice were injected with 20 µl of 
TGF-β3 (800 ng), CTGF (400 ng), or with PBS as a control, into the subcutaneous neck 
tissue once a day for 3 or 7 consecutive days. Serial injections of the two growth factors 
(TGF-β3 for days 1-3 days and CTGF for days 4-7) were also conducted (Fig. 1). The 
amounts of growth factors used in these experiments were previously shown to be optimal in 
our skin fibrotic animal models using BALB/C mice [10, 11].The mice were euthanized with 
an overdose of diethyl ether 24 hours after the final injection, and tissue samples were 
obtained from the site of injection. Parts of the tissue samples were fixed in 10% neutral 
buffered formalin and processed for routine histological examination and the measurement of 
collagen content. The remaining tissue was embedded in Tissue-Tek OCT compound (Miles, 
IN), snap frozen in liquid nitrogen, and stored at –70 OC prior to use. Ten serial 6-µm sections 
were cut from each frozen sample embedded in OCT compound. The sections were subjected 
to RNA extraction. 
 
2.4 Measurement of collagen content in tissue samples 
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Tissue samples were embedded in paraffin and sections, approximately 15 µm thick, were 
obtained. Groups of 10 to 20 sections were deparaffinized after incubation with xylol, 
xylol:ethanol (1:1), ethanol, water:ethanol (1:1), and water. We used only granulated areas of 
the sections. Individual samples were placed in small test tubes and covered with 0.2 ml of a 
saturated solution of picric acid in distilled water that contained 0.1% Fast green FCF and 
0.1% Sirius red F3BA. The samples were rinsed several times with distilled water until the 
fluid was colorless. One milliliter of 0.1 N NaOH in absolute methanol (1:1; v:v) was added 
and the eluted color was read in a spectrophotometer at 540 nm and 605 nm. The method is 
based on the selective binding of Sirius red F3BA and Fast green FCF to collagens and 
non-collagenous proteins, respectively [27]. Each experimental sample was run in triplicate. 
 
2.5 RNA isolation and cDNA synthesis 
Total RNA was extracted from frozen granulation tissue samples using RNeasy (Qiagen, 
Valencia, CA) spin columns, according to the manufacturer's protocol, with the addition of a 
DNase digestion step. RNA concentration and purity was determined spectrophotometrically 
by measuring fluorescence at 260 nM and 280 nM. Total RNA (100 µg) was reverse 
transcribed into cDNA in a total volume of 20 µg using a Reverse Transcription System 
(Promega, Madison, WI) according to the manufacturer’s instructions. 
 
2.6 Taqman quantitative real-time PCR analysis  
Four microliters of cDNA were used as a template for real-time PCR, which was carried out 
in an ABI Prism 7000 Sequence Detector System (PE Applied Biosystems, Foster city, CA). 
The sequences of the mouseα2 chain of the type I collagen (COL1A2) primers and probe 
used are 5’-CAC CCC AGC GAA GAA CTC ATA-3’ (forward), 5’-GCC ACC ATT GAT 
AGT CTC TCC TAA C-3’(reverse) and 5’-CGC CCA GGC CAA CAA GCA TGT C-3’                   
(probe). Intron-spanning primers were used to minimize the possibility of co-amplifying 
genomic DNA. The primers for MCP-1, fractalkine, CCR2, CX3CR1 and CTGF were 
purchased from Applied Biosystems. We used the Taqman rodent GAPDH control reagent 
(PE Applied Biosystems) as an internal control. PCR (1 x (50OC, 2 min, 95OC, 10 min), 40 x 
(95OC, 15 sec, 60OC, 1 min) was performed in the presence of 0.6 x Taqman Universal PCR 
master mix (PE Applied Biosystems), forward and reverse primers and a sequence- specific 
fluorescent probe. Optimal probe and primer concentrations were determined for each assay 
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to ensure maximum specificity. Relative units (RU) were calculated by the comparative CT 
method. First, the CT for the target amplification (FAM) and the CT for the endogenous control 
(VIC; GAPDH) were determined for each sample. The Difference between the CT for the 
target and the CT for the internal control, called Δ CT, was calculated to normalize for the 
differences in the amounts of total nucleic acid added to each mixture. The Δ CT of the 
calibrator was subtracted from the Δ CT of each experimental sample to give ΔΔ CT . The 
amount of target normalized to an endogenous control and relative to the calibrator, was then 
calculated using the equation 2 (-ΔΔ CT).  Each experimental sample was run in triplicate. 
 
2.7 Histological examination and immunohistochemistry 
The formalin-fixed and paraffin-embedded specimens were cut to a thickness of 4 mm and 
stained with hematoxylin and eosin. Immunohistochemical analysis using antimouse F4/80 
antibody (clone A3-1, ACM, UK), CD11b (clone M1/70, BD Biosciences, San Jose, CA), 
Gr1(clone RB6-8C5, BD Biosciences) at a dilution 1:100 was performed with biotinylated 
anti-mouse IgG as secondary antibody. Visualization was done with the standard 
streptavidin-biotin-coupled immunoperoxidase technique (Histofine kit, Nichirei, Tokyo, 
Japan). The measurement of macrophages was performed by averaging the number of cells 
identified by positive for the F4/80 or CD11b staining per visual field in five high power 
fields (magnification, x 200), respectively. Each experimental sample was run in triplicate. 
 
2.8 Macrophage isolation 
Magnetic cell sorting technology (Miltenyi Biotec, Bergisch Gladbach, Germany) was used 
to purify macrophages according to the manufacture’s instructions. CD11b microbeads were 
used to purify macrophages from spleen cells. 
 
2.9 Cell culture in vitro 
Primary fibroblast cultures were established from dorsal skin of newborn wild-type mice as 
described. Fibroblasts were grown at 37°C in a 5% CO2 atomosphere in Dulbecco’s modified 
Eagle’s medium (DMEM) (Wako Pure Chemical Industries, Osaka, Japan) with 10% fetal 
calf serum (Nunc, Roskilde, Denmark), 100 U/ml penicillin/streptomycin in 6-well 
multi-dishes. Passages 3-5 were used for the experiments. After cells reached confluence, the 
culture medium was discarded and cells were starved using DMEM with 0.1% bovine serum 
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albumin and nonessential amino acids (Sigma, St. Louis, MO) for 24 hours prior to initiating 
TGF-β3 or CTGF stimulation. TGF-β3 or CTGF was added to the cell culture medium to a 
final concentration of 10 ng/mL, 150 ng/mL after 24 hours starvation. The cells were then 
cultured for 24 hours. For macrophage-fibroblast cocultues, macrophages (5x105 cells per 
well) were added in the upper wells (insert) of a 6-well transwell plate (0.4 mm pore size; BD 
Falcon) simultaneously with TGF-β3. At the end of each experiment, total RNA was isolated 
from fibroblasts in the lower chamber using RNeasy (Qiagen, Valencia, CA) as above. To 
examine a contamination by endothelial cells, we added the FACS analyses of skin 
fibroblasts. CD31+ cells were not detected in isolated skin fibroblasts by FACS analysis (data 
not shown). 
 
2.10 Flow cytometry  
Abs used in this study included PE-conjugated anti-CCR2 mAb (R&D Systems, Minneapolis, 
MN), APC-conjugated anti-CX3CR1 mAb(R&D Systems). Single-cell suspensions of 
isolated macrophages were incubated with the Abs for 30 min at 4°C. The cells washed and 
fixed with 1% paraformaldehyde in PBS. Stained Samples were analyzed on FACSVantage 
SE (BD Biosciences), analyzing data from 105 cells. Data were analayzed using the FlowJo 
(Tree Star, Ashland,OR) software. Positive and negative populations of cells were determined 
using unreactive isotypematched mAbs (BD Biosciences) as controls for background 
staining.  
 
2.11 Statistical Analysis 
Values were expressed as the mean ± SEM. Student’s t test was used to evaluate the statistical 
differences between the groups. 
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3. Results  
3.1 Semi-quantitative analysis of collagen content in skin fibrosis induced by exogenous 
injection of TGF-β and CTGF in CCR2-KO and CX3CR1-KO mice 
We previously showed that serial injections of CTGF after TGF-β induced persistent fibrotic 
tissue formation in newborn mice [11], leading to increased amounts of deposited collagen in 
granulation tissue [12]. We next wanted to analyze the requirements for the chemokine 
receptors CCR2 and CX3CR1 in this same model system in order to examine potential roles 
for chemokines in SSc. In this study, we injected 800 ng of TGF-β on days 1-3 followed by 
400 ng of CTGF on days 4-7. Since the profibrogenic effects of TGF-β1, -β2, and -β3 were 
almost identical in previous experiments [10], we used TGF-β3 (henceforth referred to as 
TGF-β) for all experiments in the present study. 
 Serial injections of CTGF following TGF-β administration caused a prominent 
collagen accumulation in WT mice (Fig. 2A, E). By contrast, the collagen content was not 
increased in CCR2-/- mice until day 4, resulting in a significant reduction of local collagen as 
compared with WT mice (p<0.005) (Fig. 2A, C). However, during days 5-8, when CTGF was 
injected, enhanced collagen production was observed in CCR2-/- mice, resulting in equivalent 
collagen content levels in CCR2-/- mice and WT mice at day 8 (Fig. 2A, F). In CX3CR1-/- 
mice, collagen levels were decreased by approximately 50% on days 4 and 8 as compared 
with WT mice (p<0.05 and p<0.005, respectively) (Fig.2A, D, G). These semi-quantitive 
results were for the most part consistent with the histological findings. The collagen contents 
injected with PBS as control were not increased in WT, CCR2-/-, or CX3CR1-/- mice (data not 
shown).   
 
3.2 mRNA levels for the α2 chain of type 1 collagen in granulation tissues 
We next investigated mRNA levels for the α2 chain of type I collagen (COL1A2) in 
granulation tissues. The levels of COL1A2 were determined by real-time PCR and 
normalized against the GAPDH mRNA level in each sample. As shown in Figure 3, just 
TGF-β induced a significant increase in the amount of COL1A2 mRNA in WT mice on day 4 
(p<0.05). The level of COL1A2 mRNA at day 4 was reduced in CCR2-/- and CX3CR1-/- mice, 
but were still greater than that observed in WT mice in the absence of TGF-β.  These data 
suggest that the increased collagen content observed after TGF-β administration are due to 
alterations at the transcriptional level. As shown in Figure 4, CTGF following TGF-β induced 
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an increase in the amount of COL1A2 mRNA in WT mice on day 8. 
 
3.3 Profile of inflammatory cells in this animal model of skin fibrosis 
It has been reported that the numbers of macrophages are increased in fibrotic tissues [28]. In 
our model, TGF-β injection increased the number of lesional macrophages on day 4, and 
these numbers continued to increase with subsequent CTGF injections on days 4-7 [12]. The 
numbers of accumulated F4/80-positive cells on day 4 and 8 were significantly decreased in 
CCR2-/- mice, as compared to WT mice (p<0.05 and p<0.001) (Fig. 5A, C). CX3CR1-/- mice 
also exhibited an approximately 30% reduction in macrophage infiltration on day 8 (p<0.005, 
as compared to WT mice) (Fig. 5A, D). The numbers of accumulated CD11b-positive cells 
on day 4 and 8 were significantly decreased in CCR2-/- mice, as compared to WT mice 
(p<0.05 and p<0.05) (Fig. 5E). CX3CR1-/- mice also exhibited a reduction in macrophage 
infiltration on day 8 (p<0.05, as compared to WT mice) (Fig. 5E). The numbers of 
accumulated Gr1-positive cells on day 4 and 8 were not decreased in CCR2-/- and CX3CR1-/-  
mice, as compared to WT mice (Fig. 5F).  The numbers of macrophages were not increased 
in WT, CCR2-/-, or CX3CR1-/- mice injected with PBS as control (data not shown).   
 
3.4 Chemokine and chemokine receptor mRNA levels in granulation tissues 
To examine whether chemokines produced by macrophages and inflammatory cells play a 
role in skin fibrosis, we performed real-time PCR analysis. TGF-β injection increased the 
expressions of MCP-1, fractalkine, CCR2 and CX3CR1 mRNA on day 4 in WT mice (Fig. 6). 
Similarly, we examined the expression of these molecules in CCR2-/- mice and CX3CR1-/- 
mice. As expected, CCR2 and CX3CR1 mRNA were undetectable in their respective 
knock-out mice.  In CX3CR1-/- mice and CCR2-/- mice, each chemokine level was low, as 
compared to treated WT controls.  In CX3CR1-/- mice and CCR2-/- mice, each chemokine 
receptor level was low, as compared to treated WT controls. CTGF following TGF-β 
injection increased the expressions of MCP-1 and fractalkine on day 8 in WT mice (Fig. 7).   
 
3.5 Expression of CCR2 and CX3CR1 on WT Macrophages  
Flowcytometric analysis showed that WT CD11b+ gated cells expressed CCR2 and CX3CR1 
protein (Fig. 8). 
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3.6 Chemokine and chemokine receptor mRNA levels in fibroblast cultures  
In macrophage-fibroblast cocultures, cultured fibroblasts possessed increased levels of not 
only MCP-1 mRNA, but also CTGF mRNA (p<0.0005 and p<0.05), compared with 
fibroblasts cultured alone. Stimulation with TGF-β significantly augmented fractalkine and 
CTGF mRNA expression in cultured fibroblasts (p<0.0005 and p<0.0005), and tended to 
augment COL1A2 mRNA. Fibroblast stimulation with CTGF augmented CTGF mRNA 
levels (p<0.05), providing evidence for an autocrine feedback loop.  In contrast, CTGF 




In the current study using a cutaneous fibrosis model, in which fibrosis is induced by serial 
TGF-β and CTGF injections, we have shown that macrophage-related chemokines play 
important roles in the development of this condition. This is consistent with our previous 
finding of increased number of macrophages at the CTGF injection site following TGF-β 
administration [12]. The current study suggests that interactions between fibroblasts and 
immune cells, including macrophages, contribute to the induction and maintenance of fibrosis 
via increased production of cytokines and chemokines. 
 MCP-1 is produced by macrophages, fibroblasts, endothelial cells, and other cells. 
MCP-1 is the predominant chemoattractant and activator of CCR2+ monocytes and T cells. In 
addition to its chemoattractant activities, this chemokine induces Th2 cell polarization [29]. 
MCP-1 directly stimulates collagen production by fibroblasts via specific receptors and 
endogenous upregulation of TGF-β expression [16] Our in vivo data also revealed that serial 
injections of TGF-β increased MCP-1 mRNA and CCR2 mRNA levels. Conversely, the loss 
of CCR2 attenuated macrophage infiltration as well as skin fibrosis at day 4. Also, in 
macrophage-fibroblast in vitro cocultures, fibroblasts displayed increased levels of both 
MCP-1 and CTGF mRNAs. The up-regulated collagen levels induced by TGF-β were 
significantly reduced by CCR2 deficiency, while collagen levels induced by CTGF were 
unaffected. Thus, MCP-1 is required for TGF-β-mediated fibrosis induction in our mouse 
model. Collectively, the involvement of MCP-1/CCR2 interaction (CCR2-dependent loop) 
may be involved in the pathogenesis of skin fibrosis in which TGF-β plays a role. 
 Our data and previous studies estimate the following hypothesis regarding the role of 
MCP-1/CCR2 in the development of tissue fibrosis in SSc: First, MCP-1 augments the 
recruitment of CCR2-expressing macrophages and T cells into tissues, and promotes the 
interaction of CCR2+ macrophages and fibroblasts. Then, TGF-β and PDGF produced by 
activated CCR2-expressing macrophages stimulate collagen synthesis by fibroblasts. At the 
same time, MCP-1 preferentially induces T cell differentiation to Th2 cells rather than Th1 
cells, and IL-4 –secreting Th2 cells migrate to the fibroblasts. In turn, activated fibroblasts 
produce MCP-1, leading to the amplification loop for the development of tissue fibrosis. 
 Fractalkine is a membrane-bound chemokine that functions not only as a 
chemoattractant but also as an adhesion molecule. Fractalkine is expressed by endothelial 
cells that are activated by proinflammatory cytokines. The fractalkine receptor, CX3CR1, is 
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expressed on mature monocytes, NK cells, and cytotoxic effector T cells. Our data also 
revealed that serial injections of TGF-β increased fractalkine mRNA and CX3CR1 mRNA 
expression levels in granulation tissues. Additionally, the blockade of CX3CR1 attenuated 
macrophage infiltration and skin fibrosis. Furuichi et al have reported that CX3CR1 deletion 
attenuates macrophage infiltration as well as late-phase renal interstitial fibrosis and renal 
function after ischemic-reperfusion injury in a mouse model. In this model, CX3CR1 was 
found to be expressed mainly in kidney-infiltrating macrophages [30]. Our data linking 
CX3CR1 to skin fibrosis are consistent with a report stating that CX3CR1 is important for 
macrophage accumulation in the wound site and that angiogenic and profibrotic macrophage 
products are reduced in wounded skin in the absence of CX3CR1 [31]. The number of 
CX3CR1-expressing cells including monocytes were found to be increased in the lesional 
skin and lung tissues from SSc patients with diffuse cutaneous involvement [24]. Thus, 
infiltrating F4/80+ macrophages are assumed to be mostly CX3CR1 positive. Fractalkine 
augments the recruitment of CX3CR1-expressing mononuclear cells into the affected tissue 
of SSc, leading to inflammation and vascular injury. A short-lived CCR2-expressing 
macrophage subset is actively recruited to inflamed tissues, while the CX3CR1-expressing 
subset has been characterized as resident in non-inflamed tissue [15]. In the current study, we 
found that the number of accumulated macrophages was decreased in CCR2-/- mice at day 4, 
while CX3CR1-/- mice also exhibited moderately reduced macrophage infiltration at day 8. 
CX3CR1-/- mice also showed less collagen accumulation after both TGF-β and CTGF 
stimulations, as compared to WT mice. 
 In vitro, we observed that stimulation with TGF-β significantly augmented 
fractalkine expression in cultured fibroblasts. To our knowledge, this is the first study to 
demonstrate the expression of fractalkine in skin fibroblasts. Ruth et al previously reported 
increased expression of fractalkine and CX3CR1 in synovial tissue fibroblasts in rheumatoid 
arthritis (RA) patients as well as in an adjuvant-induced arthritis model in rats [32]. Our data 
revealed that stimulation with TGF-β significantly augments CTGF mRNA expression in 
cultured fibroblasts, in the absence of macrophages. Thus, the fractalkine/CX3CR1 pathway 
may play an important role in the induction of fibrosis via both direct effects on fibroblasts, 
and indirect effects mediated by cytokine release from CX3CR1-macrophages and leukocytes 
in the lesional tissues. We have demonstrated that fractalkine was strongly expressed on 
endothelial cells in the affected skin and lung tissues. Soluble fractalkine levels were 
 14 
significantly elevated in sera and were associated with the existence of digital ischemia, and 
severity of pulmonary fibrosis [24]. Other studies have shown that Raynaud’s phenomenon, a 
type of ischemia-reperfusion, usually precedes the development of skin sclerosis. Therefore, it 
is possible that endothelial cell injury caused by recurring ischemia-reperfusion induces 
inflammatory cell infiltration and cytokine production, leading to the development of tissue 
fibrosis. 
Fractalkine-dependent adhesion of monocytes is greatly enhanced by MCP-1 [33]. 
Both chemokine pathways may work independently and cooperatively to support the firm 
adhesion of monocytes in vivo. Our data demonstrated that up-regulated transcription of 
fractalkine and CX3CR1 mRNA in TGF-β-induced fibrosis tended to be reduced by CCR2 
deficiency. Also, up-regulated transcription of MCP-1 and CCR2 mRNA in TGF-β-induced 
fibrosis tended to be reduced by CX3CR1 deficiency. 
 In summary, fibrosis is a complex process that may involve multiple cytokines and 
chemokines, which crosstalk with effector cells. MCP-1/CCR2 and fractalkine/CX3CR1 play 
important roles of the induction and maintenance of fibrosis, likely via differing mechanisms. 
Therefore, these molecules should be considered as potential therapeutic targets in patients 
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Cytokine-induced fibrosis model. Serial injections of the two growth factors (TGF-β3 for 
days 1-3 days and CTGF for days 4-7) were conducted. 
 
Figure 2 
A. The amounts of collagen deposited in granulation tissues in WT mice, CCR2-/- mice, and 
CX3CR1-/- mice during injections of 800 ng of TGF-β on days 1-3 followed by injections of 
400 ng of CTGF on days 4-7. Control WT mice were treated with PBS. Values are the mean ± 
SEM of 4-7 mice in each group. *p<0.05 , **p<0.01, *** p<0.005. B-G. Representative 
histopathology from WT mice (B), CCR2-/- mice (C), and CX3CR1-/- mice (D) on day 4, and 
WT mice (E), CCR2-/- mice (F), and CX3CR1-/- mice (G) on day 8. 
 
Figure 3 
mRNA levels for the α2 chain of type I collagen in granulation tissues from WT mice, 
CCR2-/- mice, and CXCR3-/- mice on day 4 after TGF-β injections. The expression levels of 
COL1A2 mRNA were determined by real-time PCR and normalized against the GAPDH 




mRNA levels for the α2 chain of type I collagen in granulation tissues from WT mice, 
CCR2-/- mice, and CXCR3-/- mice on day 8 after CTGF  following TGF-β injections. The 
expression levels of COL1A2 mRNA were determined by real-time PCR and normalized 
against the GAPDH mRNA expression level in each sample. Values are the mean of 4-6 mice 
in each group. *p<0.05. 
 
Figure 5 
Kinetics of macrophage recruitment assessed by immunohistochemical analysis using 
anti-mouse F4/80, CD11b and Gr1 antibody. WT , CCR2-/-, and CX3CR1-/- mice were 
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injected with TGF-β and CTGF. Control WT mice were injected with PBS. A. The total 
numbers of F4/80-positive cells counted in five high power fields at x200 are shown. B-D. 
Representative photographs from WT mice (B), CCR2-/- mice (C), and CX3CR1-/- mice (D) on 
day 8. E. The total numbers of CD11b-positive cells counted in five high power fields at x200 
are shown. F. The total numbers of Gr1-positive cells counted in five high power fields at 
x200 are shown. Values are the mean of ± SEM from 4-7 mice in each group. *p<0.05, 
**p<0.005 , ***p<0.001. 
 
Figure 6 
mRNA levels of chemokines and chemokine receptors in granulation tissues on day 4. The 
expression levels of MCP-1, fractalkine, CCR2, and CX3CR1 mRNA in granulation tissues 
from WT mice, CCR2-/- mice, and CXCR1-/- mice 4 days after TGF-β injections were 
determined by real-time PCR and normalized against the GAPDH mRNA transcript level in 
each sample. Values are the mean of 4-6 mice in each group. *p<0.05, **p<0.005. 
 
Figure 7 
mRNA levels of chemokines and chemokine receptors in granulation tissues on day 8. The 
expression levels of MCP-1 and fractalkine mRNA in granulation tissues from WT mice, 
CCR2-/- mice, and CXCR1-/- mice 8 days after CTGF following TGF-b injections were 
determined by real-time PCR and normalized against the GAPDH mRNA transcript level in 
each sample. Values are the mean of 4-6 mice in each group. 
 
Figure 8 
Representative histgrams of CCR2 and CX3CR1 expression on WT Macrophages. Bold lines 
(open regions) in the histgram represent  WT CD11b-gaeted cells, and thin lines (shaded 
regions) in the hidtogram reperesent isotype control staining.   
 
Figure 9 
Chemokines and chemokine receptor mRNA levels from in vitro-cultured fibroblasts. 
Primary fibroblast cultures were established from dorsal skin of newborn WT mice. TGF-β or 
CTGF was added to the cell culture medium to a final concentration of 10 ng/ml or 150 ng/ml, 
respectively. For macrophage-fibroblast cocultures, macrophages (5x105 cells per well) were 
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added to the upper wells. Total RNA was isolated from only fibroblasts, and expression levels 
were determined by real-time PCR and normalized against the GAPDH mRNA transcript 
level in each sample. Results were obtained from 4 samples in each group. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0005. 
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